Skip to content

Clinical research on the necessity of scar tissue resection during intrauterine adhesions

Clinical research on the necessity of scar tissue resection during intrauterine adhesions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048272
Enrollment
Unknown
Registered
2021-07-05
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrauterine adhesions

Interventions

Experimental group:Scar tissue is removed
Control group:Scar tissue is not removed

Sponsors

The First Affiliated Hospital of Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 42 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for intrauterine adhesions in the ''Chinese Expert Consensus on Clinical Diagnosis and Treatment of Intrauterine Adhesion'': those who have a history of induced abortion or other uterine cavity surgery in the past, accompanied by periodic abdominal pain, oligomenorrhea, amenorrhea, repeated miscarriage, infertility, and have intrauterine adhesions found by hysteroscopy at the same time, those who have fertility requirements; 2. According to the American Reproductive Association Prognostic Classification AFS score is moderate and severe intrauterine adhesions, that is, the score range is 5-12 points; 3. The age range of the patients is 20-42 years old; 4. Normal endocrine function and ovulation; 5. The patient's clinical data is comprehensive and the postoperative follow-up is accepted.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiovascular and cerebrovascular diseases, liver and kidney dysfunction and other systemic diseases; 2. Those who have recently received female reproductive system surgery or have too high uterine curvature and cannot accept hysteroscopy and surgery; 3. Amenorrhea, recurrent miscarriage and infertility caused by neuro-endocrine system disorders or congenital reproductive structural abnormalities and other factors; 4. Those who have allergic reactions to estrogen and other drugs; 5. Spouse semen is seriously abnormal.

Design outcomes

Primary

MeasureTime frame
Endometrial thickness;Menstrual quantity;Endometrial blood flow resistance index (RI), pulse index (PI);

Countries

China

Contacts

Public ContactMa Yingchun

Shandong First Medical University

yingchunma74@163.com+86 15550002905

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026